Work

Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer

Year: 2020

Type: article

Study design: Case Report

Source: Clinical Breast Cancer

DOI: 10.1016/j.clbc.2020.02.003

Authors: Benjamin M. Parsons, David R. Meier, Craig S. Richmond, Grzegorz T. Gurda, Kristopher A. Lofgren, Mark E. Burkard, Dustin A. Deming, Paraic A. Kenny

Institutions: Gundersen Health System, University of Wisconsin–Madison

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AbbVie, Gundersen Medical Foundation, Genentech, Loxo Oncology, National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W3007291126

FWCI: 1.546

Cites: 24

Cited by: 17

Related to: 10